Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

Radiolabeled metaiodobenzylguanidine (mIBG) is a highly sensitive and specific marker for detecting neuroblastoma. A semiquantitative mIBG score (Curie score [CS]) was assessed for utility as a prognostic indicator for a cohort of patients with highrisk metastatic disease. METHODS: mIBG scans from 2...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Nucl Med
Main Authors: Yanik, Gregory A., Parisi, Marguerite T., Shulkin, Barry L., Naranjo, Arlene, Kreissman, Susan G., London, Wendy B., Villablanca, Judith G., Maris, John M., Park, Julie R., Cohn, Susan L., McGrady, Patrick, Matthay, Katherine K.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503147/
https://ncbi.nlm.nih.gov/pubmed/23440556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.112.112334
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki